Steam power against diabetes: new device zaps gut to control blood sugar

NCT ID NCT07355270

Recruiting now Disease control Sponsor: Aqua Medical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a device that uses radiofrequency energy to create vapor and ablate (remove) a small part of the upper intestine. The idea is that this might improve how the body handles sugar. The study will enroll 20 adults with type 2 diabetes to see if the procedure is safe and tolerable, and if it helps lower blood sugar levels over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Radiofrequency vapor ablation device (Aqua Medical RF Vapor System)
What this could lead to: If it works, this could offer a new, non-surgical way to help control blood sugar in people with type 2 diabetes, potentially reducing the need for medication.
What could go wrong: This is a very early, small pilot study with only 20 people. The main goal is safety, not yet proof of effectiveness. The procedure involves ablating intestinal tissue, which carries risks like pain or injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

Hoag Memorial Hospital Presbyterian
RECRUITING

Newport Beach, California, 92663, United States
HonorHealth Research Institute
RECRUITING

Scottsdale, Arizona, 85258, United States
Mayo Clinic
RECRUITING

Scottsdale, Arizona, 85054, United States
University of North Carolina School of Medicine
RECRUITING

Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.